July 28, 2026

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A 55% Potential Upside Amidst Innovative Therapies

Investors eyeing the biotechnology sector will find Celldex Therapeutics, Inc. (NASDAQ: CLDX) a compelling opportunity, especially with a projected upside of 55.59% according to analysts’ average..

Evotec SE (EVO) Stock Analysis: Exploring a 96.5% Potential Upside Despite Current Challenges

Evotec SE (EVO), a prominent player in the healthcare sector, specializes in drug discovery and development with a focus on addressing a broad spectrum of diseases...

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Closer Look at its 26.59% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a leading operator in the healthcare sector’s medical care facilities industry, presents an intriguing opportunity for investors looking to capitalize..

Schrodinger, Inc. (SDGR) Stock Analysis: Understanding the 34.63% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the Healthcare sector, specifically within Health Information Services, provides a unique investment opportunity with its innovative approach to..

Certara, Inc. (CERT) Stock Analysis: A Healthcare Investment with Limited Upside Potential

Certara, Inc. (NASDAQ: CERT), a key player in the health information services industry, is gaining traction among investors with its innovative technology-driven services and software products...

Neogen Corporation (NEOG): Investor Outlook Reveals 28% Potential Upside Amid Challenging Metrics

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specifically within medical devices, has captured investor attention with its potential upside of 28.48%. Despite..

ARS Pharmaceuticals (SPRY) Stock Analysis: A Potential 364% Upside in Biotech Innovator

Investors looking for compelling opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) particularly intriguing. With a significant market cap of $571.99 million..

Amphastar Pharmaceuticals, Inc. (AMPH) Investor Outlook: Evaluating a 14.70% Potential Upside

Investors eyeing Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) may find the current market conditions intriguing, given the company’s promising 14.70% potential upside. Amphastar, a key player in..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with Diverse Offerings in the Healthcare Sector

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector, is carving a niche in the drug manufacturing industry with its diverse portfolio that..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 45.60% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has been capturing attention in the biotechnology sector with its innovative approach to precision medicine oncology. With a market capitalization of..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 36% Upside Potential in Biotech Innovation

Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector, attracting keen interest from investors with its innovative approach to hematologic disease treatment. With..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Promising Biotech with a 115% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a biopharmaceutical company at the forefront of developing transformative therapies, presents an enticing proposition for investors looking to capitalize on the..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator Poised for 60% Upside

Artivion, Inc. (NASDAQ: AORT), a dynamic player in the healthcare sector specializing in medical devices, is attracting investor interest with its promising outlook and robust product..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 252.82% Potential Upside with Strong Buy Ratings

Investors eyeing the healthcare sector may want to turn their attention to Opko Health, Inc. (NASDAQ: OPK), a company that presents a compelling investment opportunity with..

Azenta, Inc. (AZTA) Investor Outlook: Navigating a Challenging Landscape with Strategic Partnerships

Azenta, Inc. (NASDAQ: AZTA) stands at an intriguing crossroads, poised between growth opportunities and operational challenges. As a player in the healthcare sector’s Medical Instruments &..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Can 44.7% Revenue Growth Justify Its Sky-High Forward P/E?

For investors looking at the potential of Establishment Labs Holdings Inc (NASDAQ: ESTA), the healthcare company specializing in medical devices, particularly breast implants under the Motiva..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Potential with a Strong 20.89% Return on Equity

For investors seeking opportunities in the healthcare sector, Pediatrix Medical Group, Inc. (NASDAQ: MD) presents a compelling, albeit complex, profile. With a market capitalization of $2.15..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: An Insightful Look at Potential 53% Upside

In the rapidly evolving biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a noteworthy contender. This clinical-stage company is focused on developing innovative therapeutics..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Navigating Growth with a 4.9% Upside Potential

BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, is making waves with its innovative contributions..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Evaluating a 26.74% Potential Upside Amidst Volatile Revenue Growth

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a notable player in the biotechnology sector, primarily focused on rare disorders. With a market capitalization of $6.29 billion,..

Search

Funds

July 28, 2026

Search

Funds

July 28, 2026

FTSE 100

Funds